You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 101 to 125 of about 6087
Next 25
02/16/2026
‘Incredibly excited’: Richard Scolyer hails new US trial for brain cancer
Musella Foundation Awards Multiple Research Grants
Upcoming webinar!
New Molecule Blocks Deadliest Brain Cancer at Its Genetic Root
02/09/2026
College scholarship opportunity for NY/NJ/CT pediatric brain tumor survivors
Artwork needed!
NCCN commemorates World Cancer Day with new commitment to update patient resources
Itaconate identified as a new target for pediatric brain tumors called ependymomas
Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial
02/02/2026
New Publication Highlights GB13 as a Promising Therapeutic Strategy for DIPG
Non-invasive Approach Predicts Chemotherapy Response in Glioblastoma
Copayment assistance program now open!
01/26/2026
Meningiomas Slowed By Targeted Therapy, Shows NCI Clinical Trials Network Group
Artwork Needed!
13th Annual Penn Brain Tumor Symposium
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy
01/19/2026
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
Digital Twin Maps Tumor Metabolism to Guide Brain Cancer Treatment
Researchers Discover PGBD5 Guides Normal Brain Development in Addition to Causing Cancers
GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma
01/15/2026
Musella Foundation Copayment Progam now closed to new and renewal applications
01/13/2026
Webinar recording available!
01/12/2026
Penn State advances pediatric cancer research through new targeted therapy collaboration
FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot
Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression